Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04973605
Title Treatment of Relapsed/Refractory Multiple Myeloma With t 11;14 Translocation Using BGB-11417 With Dexamethasone; Also Using BGB-11417 in Combination With Dexamethasone and Carfilzomib.
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BeiGene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NZL | GBR | CAN | BRA | AUS


No variant requirements are available.